Blog July 10, 2024 The Power of Connection: Insights from the Global Exchange Program Earlier this year, Syneos Health Communications launched its first Global Exchange Program, a 6-month initiative that gave team members the opportunity to immerse themselves in their partner office’s daily work ...
As a result, our updated guidance range now reflects the trends in the second half of 2024 could be higher than levels seen in the first half. It is worth knowing that if trends persist at elevated levels, we may be required to take an in year 2024 premium deficiency reserve in our Med...
Flatiron HealthandOscarcreated the first cohort of health tech alumni networks, the talent that has matured alongside the industry over the last decade will usher in the next wave.
There is no generic equivalent available for the type of insulin my son has to take for his diabetes and my insurance provider considers it non-formulary. That ONE medication of his is $60 per month. This does not include his other insulin, his needles, or his test strips. There IS a ...
While efforts to increase rigor in the evaluation of mHealth solutions are still taking shape, many questions remain on best practices and frameworks for mHealth development upstream of final regulatory or formulary approval. The Clinical Trials Transformation Initiative (CTTI) provides one of the ...
The extent of coverage can vary based on the plan’s formulary. It’s important to note that the specifics of what is covered and the extent of coverage can vary depending on the health insurance plan. Parents should review their health insurance policy details or contact their insurance ...
et al. Utilization and affordability of health insurance coverage for rare disease drugs in a first-tier city in Northeast China from 2018 to 2021: a study based on the health insurance claims database. Int J Equity Health 23, 151 (2024). https://doi.org/10.1186/s12939-024-02225-0 ...
cost-effective care. We are proud to offer solutions that give you the insights, tools and expert support you need to make decisions related to biosimilar adoption. From biosimilar distribution services and contracted pricing, to providing robust analytics around your formulary, Cardinal Health can he...
December 21st 2024 A Motor Neuron Mystery Points to New Potential SMA Treatment Targets ByRyan Flinn December 21st 2024 Are the Big PBMs Putting the GLPs on Their Formularies? We took a look. But just because it's on a national formulary doesn't mean a health plan will cover it. ...
And some seven-figure CEO has me spending my time begging someone to authorize a generic that's not on his formulary. But to poke this bear in the eye, we may stir up income control on "providers," you know, "doctors." What about my orthopedic surgeon? Well, he accepts my Medicare,...